Is a Reporting System for Gastritis or Duodenitis (Modified Lanza Scale) Reproducible?
NCT ID: NCT00852150
Last Updated: 2012-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2009-03-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method: During upper endoscopic examinations, one investigator performed the procedure and the second investigator look at the endoscopic image. The degree of gastritis and duodenitis is graded. The results of the grading are blinded to the other investigator.
The endoscopic video is stored for reassessment to determine the intra-rater reliability. The patient identifier is stored in serial number. The investigator will not retrieve the report of the first assessment during the second assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy
NCT01896310
AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis
NCT05916014
Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis
NCT04923113
Objective Study on Tongue Diagnosis of Chronic Atrophic Gastritis
NCT06489132
Magnifying NBI Endoscopy for Gastric Condition
NCT04489030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruttonjee Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fook-Hong Ng
SMO
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fook Hong Ng, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Medicine, Ruttonjee Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruttonjee Hospital
Wan Chai, Hong Kong, China
Ruttonjee Hospital
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKEC 2008-083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.